Direct Oral Anticoagulants

Thomas G. DeLoughery

doi:10.1007/978-3-030-19330-0_24

Direct Oral Anticoagulants

Thomas G. DeLoughery

Knight Cancer Institute

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter reviews the new direct oral anticoagulants - thrombin and Xa inhibitors. The specific drugs are reviewed as well as the specific indications - prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs in are reviewed.

Original language	English (US)
Title of host publication	Hemostasis and Thrombosis
Subtitle of host publication	Fourth Edition
Publisher	Springer International Publishing
Pages	155-159
Number of pages	5
ISBN (Electronic)	9783030193300
ISBN (Print)	9783030193294
DOIs	https://doi.org/10.1007/978-3-030-19330-0_24
State	Published - Jan 1 2019

Keywords

Apixaban
Betrixaban
Dabigatran
Edoxaban
Rivaroxaban

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-19330-0_24

Cite this

@inbook{77502004d76840d08fec825d275e551e,

title = "Direct Oral Anticoagulants",

abstract = "This chapter reviews the new direct oral anticoagulants - thrombin and Xa inhibitors. The specific drugs are reviewed as well as the specific indications - prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs in are reviewed.",

keywords = "Apixaban, Betrixaban, Dabigatran, Edoxaban, Rivaroxaban",

author = "DeLoughery, {Thomas G.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019.",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-19330-0_24",

language = "English (US)",

isbn = "9783030193294",

pages = "155--159",

booktitle = "Hemostasis and Thrombosis",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Direct Oral Anticoagulants

AU - DeLoughery, Thomas G.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2019.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This chapter reviews the new direct oral anticoagulants - thrombin and Xa inhibitors. The specific drugs are reviewed as well as the specific indications - prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs in are reviewed.

AB - This chapter reviews the new direct oral anticoagulants - thrombin and Xa inhibitors. The specific drugs are reviewed as well as the specific indications - prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs in are reviewed.

KW - Apixaban

KW - Betrixaban

KW - Dabigatran

KW - Edoxaban

KW - Rivaroxaban

UR - http://www.scopus.com/inward/record.url?scp=85148794068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148794068&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-19330-0_24

DO - 10.1007/978-3-030-19330-0_24

M3 - Chapter

AN - SCOPUS:85148794068

SN - 9783030193294

SP - 155

EP - 159

BT - Hemostasis and Thrombosis

PB - Springer International Publishing

ER -

Direct Oral Anticoagulants

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this